SecBot SecBot
DEF 14A ·Filed Oct 19, 2026

TTRX

Turn Therapeutics Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed7d 5h ago SEC0001213900-26-110670
Definitive proxy statement
Actionable Insight • Neutral

Monitor the annual meeting outcome for any withheld-vote percentage against the two insider nominees (Burnam/Ghodadra) as a gauge of minority shareholder sentiment. The stockholders agreement giving Burnam veto power over major decisions is a structural governance feature that could become relevant in any future M&A or financing discussions.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+1d
TTRX ▼ -3.06% at T+1d
NEUTRAL call -3.06% · α vs SPY -3.58% · entry $10.47 → $10.15
Next anchor: T+5d due 14h ago
Latest observation: T+3 +3.82% FF3 residual α
Entry = T+0 close
Oct 19, 2026
via day close
T+1d
-3.06%
call -3.06% · α -3.58%
$10.15
settled 7d ago
T+5d
Pending
due 14h ago
T+20d
Pending
in 20d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Turn Therapeutics Inc. filed its definitive proxy statement for the 2026 annual meeting, seeking to re-elect CEO Bradley Burnam and CMO Dr. Neil Ghodadra as Class I directors and to ratify the appointment of WithumSmith+Brown as auditor. CEO Burnam controls 49.51% of outstanding shares through BEB Holdings, LLC, and a stockholders agreement grants him veto power over major corporate actions as long as he holds at least 10% of shares. The filing is routine with no shareholder proposals, contested elections, or material governance changes.

Key Facts

  • Annual meeting to be held virtually on November 30, 2026; record date October 5, 2026 with 30,532,704 shares outstanding
  • Proposal 1: Elect Bradley Burnam (CEO) and Dr. Neil Ghodadra (CMO) as Class I directors for three-year terms
  • Proposal 2: Ratify WithumSmith+Brown, PC as independent auditor for FY2026
  • CEO Bradley Burnam beneficially owns 49.51% of shares via BEB Holdings, LLC
  • Stockholders agreement with Burnam requires his approval for major transactions, equity issuances over $50M, charter/bylaw amendments, and CEO/CFO hiring
  • Director Arthur Golden serves as investment advisor to two irrevocable trusts holding 600,000 shares gifted by Burnam to his children
  • Davis Polk (where Golden is senior counsel) received ~$1.5M in legal fees in 2025 for Direct Listing work
  • CEO Burnam 2025 total compensation: $652,036 (salary $465,740 + bonus $186,296); CFO Chaudhary: $1,426,754 (salary $152,211 + bonus $30,400 + $1,244,143 option award grant date fair value)
  • Audit committee is fully independent; audit fees paid to Withum in 2025: $351,000
  • No shareholder proposals, no contested director elections, no say-on-pay vote

Financial Impact

No material financial impact from this routine proxy filing. CEO compensation of $652K and CFO compensation of $1.43M (including $1.24M option grant) are disclosed but not subject to shareholder vote.

Risk Factors

  • CEO Burnam's 49.51% ownership and veto rights in stockholders agreement concentrate control and could deter potential acquirers or activist investors
  • Director Golden's dual role as Davis Polk senior counsel and investment advisor to Burnam family trusts creates related-party complexity
  • Auditor change from SetApart to Withum in April 2025 adds incremental governance scrutiny

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEF 14A Filing (Primary)0001213900-26-110670
Document: 0001213900-26-110670-index-headers.html0001213900-26-110670
Document: 0001213900-26-110670-index.html0001213900-26-110670
Document: 0001213900-26-110670.txt0001213900-26-110670
14 reports for TTRX
Performance horizon
83% Hit rate @ T+60 5 of 6 directional calls Went positive at some point 6 of 7 best @ T+60▲ +115.10%May 18, 2026
Filters
Rows
Reports for TTRX — sortable, filterable
TypeNow
Oct 19, 2026
7d ago
DEF 14A
NEUTRAL ★ 3/10
$10.47awaiting T+60—$10.61 (+1.34%)
Oct 6, 2026
20d ago
8-K
NEUTRAL ★ 5/10
$12.10awaiting T+60—$10.61 (−12.31%)
Sep 10, 2026
6w ago
8-K
NEUTRAL ★ 3/10
$13.38awaiting T+60—$10.61 (−20.70%)
Sep 9, 2026
6w ago
8-K
BULLISH ★ 5/10
$13.75awaiting T+60—$10.61 (−22.84%)
Aug 18, 2026
9w ago
8-K
NEUTRAL ★ 4/10
$9.99awaiting T+60—$10.61 (+6.21%)
Jul 7, 2026
15w ago
8-K
BULLISH ★ 7/10
$9.71 $14.39▲ +48.20%▲ +46.20%$10.61 (+9.27%)
Jun 3, 2026
20w ago
8-K
BULLISH ★ 7/10
$6.02 $10.11▲ +67.94%▲ +65.44%$10.61 (+76.25%)
Jun 1, 2026
21w ago
8-K
BULLISH ★ 6/10
$6.33 $9.73▲ +53.71%▲ +52.48%$10.61 (+67.61%)
May 27, 2026
21w ago
8-K
BULLISH ★ 5/10
$5.29 $9.54▲ +80.34%▲ +78.46%$10.61 (+100.57%)
May 19, 2026
22w ago
8-K
NEUTRAL ★ 2/10
$4.55 $9.86▲ +116.70%▲ +110.41%$10.61 (+133.19%)
Showing 10 of 14

US Market Status

Market Closed — Opens Wed (11h 33m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 19, 2026